BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 21435183)

  • 1. coral Software: QSAR for Anticancer Agents.
    Benfenati E; Toropov AA; Toropova AP; Manganaro A; Gonella Diaza R
    Chem Biol Drug Des; 2011 Jun; 77(6):471-6. PubMed ID: 21435183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. QSAR models for toxicity of organic substances to Daphnia magna built up by using the CORAL freeware.
    Toropova AP; Toropov AA; Benfenati E; Gini G
    Chem Biol Drug Des; 2012 Mar; 79(3):332-8. PubMed ID: 22136580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CORAL: QSPR model of water solubility based on local and global SMILES attributes.
    Toropov AA; Toropova AP; Benfenati E; Gini G; Leszczynska D; Leszczynski J
    Chemosphere; 2013 Jan; 90(2):877-80. PubMed ID: 22921649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. QSAR as a random event: modeling of nanoparticles uptake in PaCa2 cancer cells.
    Toropov AA; Toropova AP; Puzyn T; Benfenati E; Gini G; Leszczynska D; Leszczynski J
    Chemosphere; 2013 Jun; 92(1):31-7. PubMed ID: 23566368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SMILES-based QSAR approaches for carcinogenicity and anticancer activity: comparison of correlation weights for identical SMILES attributes.
    Toropov AA; Toropova AP; Benfenati E; Gini G; Leszczynska D; Leszczynski J
    Anticancer Agents Med Chem; 2011 Dec; 11(10):974-82. PubMed ID: 22023046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CORAL: quantitative structure-activity relationship models for estimating toxicity of organic compounds in rats.
    Toropova AP; Toropov AA; Benfenati E; Gini G; Leszczynska D; Leszczynski J
    J Comput Chem; 2011 Sep; 32(12):2727-33. PubMed ID: 21656789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SMILES-based QSAR models for the calcium channel-antagonistic effect of 1,4-dihydropyridines.
    Veselinović AM; Milosavljević JB; Toropov AA; Nikolić GM
    Arch Pharm (Weinheim); 2013 Feb; 346(2):134-9. PubMed ID: 23280520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SMILES-based QSAR model for arylpiperazines as high-affinity 5-HT(1A) receptor ligands using CORAL.
    Veselinović AM; Milosavljević JB; Toropov AA; Nikolić GM
    Eur J Pharm Sci; 2013 Feb; 48(3):532-41. PubMed ID: 23287365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. QSAR analysis of 1,4-dihydro-4-oxo-1-(2-thiazolyl)-1,8-naphthyridines with anticancer activity.
    Atanasova M; Ilieva S; Galabov B
    Eur J Med Chem; 2007 Sep; 42(9):1184-92. PubMed ID: 17408810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. QSPR modeling bioconcentration factor (BCF) by balance of correlations.
    Toropov AA; Toropova AP; Benfenati E
    Eur J Med Chem; 2009 Jun; 44(6):2544-51. PubMed ID: 19232785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of retention characteristics of heterocyclic compounds.
    Nesměrák K; Toropov AA; Toropova AP; Yildiz I; Yalcin I; Brozikova M; Klimešová V; Waisser K
    Anal Bioanal Chem; 2015 Dec; 407(30):9185-9. PubMed ID: 26427498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. QSPR modelling of dielectric constants of π-conjugated organic compounds by means of the CORAL software.
    Achary PG
    SAR QSAR Environ Res; 2014; 25(6):507-26. PubMed ID: 24716837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CORAL: building up the model for bioconcentration factor and defining it's applicability domain.
    Toropov AA; Toropova AP; Lombardo A; Roncaglioni A; Benfenati E; Gini G
    Eur J Med Chem; 2011 Apr; 46(4):1400-3. PubMed ID: 21295893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SMILES-based optimal descriptors: QSAR modeling of carcinogenicity by balance of correlations with ideal slopes.
    Toropov AA; Toropova AP; Benfenati E
    Eur J Med Chem; 2010 Sep; 45(9):3581-7. PubMed ID: 20570021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CORAL Software: Analysis of Impacts of Pharmaceutical Agents Upon Metabolism via the Optimal Descriptors.
    Toropova MA; Raska I; Toporova AP; Raskova M
    Curr Drug Metab; 2017; 18(6):500-510. PubMed ID: 28260514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SMILES-based optimal descriptors: QSAR analysis of fullerene-based HIV-1 PR inhibitors by means of balance of correlations.
    Toropov AA; Toropova AP; Benfenati E; Leszczynska D; Leszczynski J
    J Comput Chem; 2010 Jan; 31(2):381-92. PubMed ID: 19479738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SMILES-based quantitative structure-property relationships for half-wave potential of N-benzylsalicylthioamides.
    Nesmerak K; Toropov AA; Toropova AP; Kohoutova P; Waisser K
    Eur J Med Chem; 2013 Sep; 67():111-4. PubMed ID: 23850571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CORAL: QSAR models for acute toxicity in fathead minnow (Pimephales promelas).
    Toropova AP; Toropov AA; Lombardo A; Roncaglioni A; Benfenati E; Gini G
    J Comput Chem; 2012 May; 33(12):1218-23. PubMed ID: 22371019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monte Carlo QSAR models for predicting organophosphate inhibition of acetycholinesterase.
    Veselinović JB; Nikolić GM; Trutić NV; Živković JV; Veselinović AM
    SAR QSAR Environ Res; 2015 Jun; 26(6):449-60. PubMed ID: 26043064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quasi-SMILES: quantitative structure-activity relationships to predict anticancer activity.
    Toropova AP; Toropov AA
    Mol Divers; 2019 May; 23(2):403-412. PubMed ID: 30306392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.